SK Plasma Co., Ltd.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 2015-03-05
- Employees
- 11
- Market Cap
- -
- Website
- http://www.skplasma.com
An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- SK Plasma Co., Ltd.
- Target Recruit Count
- 55
- Registration Number
- NCT06738901
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation
Phase 2
Terminated
- Conditions
- Liver Transplantation
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- SK Plasma Co., Ltd.
- Target Recruit Count
- 59
- Registration Number
- NCT05666453
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)
Phase 3
Completed
- Conditions
- Immune Thrombocytopenia
- Interventions
- Biological: LIV-GAMMA SN Inj.10%
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2022-10-05
- Lead Sponsor
- SK Plasma Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT05566990
- Locations
- π°π·
Dong-A University Hospital, Busan, Korea, Republic of
π°π·Kosin University Gospel Hospital, Busan, Korea, Republic of
π°π·Pusan National University Hospital, Busan, Korea, Republic of
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)
Phase 3
Completed
- Conditions
- Immune Thrombocytopenia
- Interventions
- Biological: LIV-GAMMA SN Inj.
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- SK Plasma Co., Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT03164915
- Locations
- π°π·
Busan National University Hospital, Busan, Korea, Republic of
π°π·Bundang Seoul National University Hospital, Seongnam, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Korea, Republic of